Literature DB >> 28449776

Incident Myocardial Infarction and Very Late Stent Thrombosis in Outpatients With Stable Coronary Artery Disease.

Gilles Lemesle1, Olivier Tricot2, Thibaud Meurice3, Robert Lallemant4, Maxence Delomez3, Octave Equine5, Nicolas Lamblin6, Christophe Bauters7.   

Abstract

BACKGROUND: Current data are lacking for incidence, correlates, and prognosis associated with incident myocardial infarction (MI) in patients with stable coronary artery disease (CAD). Furthermore, the contribution of very late stent thrombosis (VLST) to these events remains poorly understood.
OBJECTIVES: This study aimed to analyze the residual risk of MI, together with relevant associated factors, and related mortality in stable CAD outpatients.
METHODS: The multicenter CORONOR (Suivi d'une cohorte de patients COROnariens stables en region NORd-Pas-de-Calais) study enrolled 4,184 unselected outpatients with stable CAD (i.e., MI or coronary revascularization >1 year previously). Five-year follow-up was achieved for 4,094 patients (98%).
RESULTS: We identified a linear risk of incident MI (0.8% annually), with ST-segment elevation MI constituting one-third of all cases. Current smoking, low-density lipoprotein cholesterol, multivessel CAD, diabetes with glycosylated hemoglobin >7%, and persistent angina were all associated with increased risk, and prior bypass surgery was associated with decreased risk. When used as a time-dependent variable, incident MI was associated with an increased risk of death (hazard ratio: 2.05; p < 0.0001). Among patients with prior stent implantation, VLST was causal in 20% of MI cases and presented more often as ST-segment elevation MI versus MI not related to a stented site (59% vs. 26%, p = 0.001). Adjusted mortality was 4 times higher in patients with VLST than in MI not related to a stented site.
CONCLUSIONS: In stable CAD outpatients, incident MI occurs at a stable rate of 0.8% annually, is related to VLST in one-fifth of cases, and is associated with an increased mortality risk, especially for VLST. Multivessel CAD and residual uncontrolled risk factors are strongly associated with MI.
Copyright © 2017 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  coronary artery disease; myocardial infarction; percutaneous coronary intervention; secondary prevention; stent thrombosis

Mesh:

Year:  2017        PMID: 28449776     DOI: 10.1016/j.jacc.2017.02.050

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  11 in total

Review 1.  Coronary Stent Thrombosis- Predictors and Prevention.

Authors:  Helen Ullrich; Thomas Münzel; Tommaso Gori
Journal:  Dtsch Arztebl Int       Date:  2020-05-01       Impact factor: 5.594

2.  Predictors of Incomplete Occlusion following Pipeline Embolization of Intracranial Aneurysms: Is It Less Effective in Older Patients?

Authors:  N Adeeb; J M Moore; M Wirtz; C J Griessenauer; P M Foreman; H Shallwani; R Gupta; A A Dmytriw; R Motiei-Langroudi; A Alturki; M R Harrigan; A H Siddiqui; E I Levy; A J Thomas; C S Ogilvy
Journal:  AJNR Am J Neuroradiol       Date:  2017-09-14       Impact factor: 3.825

3.  Post-discharge and long-term follow-up after an acute coronary syndrome: International Collaborative Group of CNCF position paper.

Authors:  Pierre Sabouret; Gilles Lemesle; Anne Bellemain-Appaix; Pierre Aubry; Pier-Paolo Bocchino; Erik Rafflenbeul; Loïc Belle; Jim Nolan; Marco Bernardi; Giuseppe Biondi-Zoccai; Michael P Savage; Maciej Banach; Guillaume Cayla
Journal:  Arch Med Sci       Date:  2022-06-23       Impact factor: 3.707

4.  Incidence and determinants of cerebrovascular events in outpatients with stable coronary artery disease.

Authors:  Charlotte Cordonnier; Gilles Lemesle; Barbara Casolla; Matthieu Bic; François Caparros; Nicolas Lamblin; Christophe Bauters
Journal:  Eur Stroke J       Date:  2018-04-30

5.  Long-term prognostic impact of left ventricular remodeling after a first myocardial infarction in modern clinical practice.

Authors:  Christophe Bauters; Emilie Dubois; Sina Porouchani; Eric Saloux; Marie Fertin; Pascal de Groote; Nicolas Lamblin; Florence Pinet
Journal:  PLoS One       Date:  2017-11-27       Impact factor: 3.240

6.  International Validation of the Thrombolysis in Myocardial Infarction (TIMI) Risk Score for Secondary Prevention in Post-MI Patients: A Collaborative Analysis of the Chronic Kidney Disease Prognosis Consortium and the Risk Validation Scientific Committee.

Authors:  Yejin Mok; Shoshana H Ballew; Lori D Bash; Deepak L Bhatt; William E Boden; Marc P Bonaca; Juan Jesus Carrero; Josef Coresh; Ralph B D'Agostino; C Raina Elley; F Gerry R Fowkes; Sun Ha Jee; Csaba P Kovesdy; Kenneth W Mahaffey; Girish Nadkarni; Eric D Peterson; Yingying Sang; Kunihiro Matsushita
Journal:  J Am Heart Assoc       Date:  2018-07-07       Impact factor: 5.501

7.  Stable atypical chest pain with negative anatomical or functional diagnostic test: Diagnosis no matter what or prevention at any cost?

Authors:  Deborah Cosmi; Beatrice Mariottoni; Franco Cosmi
Journal:  Clin Cardiol       Date:  2019-08-20       Impact factor: 2.882

8.  Association of Diabetic Status and Glycemic Control With Ischemic and Bleeding Outcomes in Patients With Stable Coronary Artery Disease: The 5-Year CORONOR Registry.

Authors:  Gilles Lemesle; Thibaud Meurice; Olivier Tricot; Nicolas Lamblin; Christophe Bauters
Journal:  J Am Heart Assoc       Date:  2018-05-04       Impact factor: 5.501

9.  A scoring system to predict the occurrence of very late stent thrombosis following percutaneous coronary intervention for acute coronary syndrome.

Authors:  Xiang Wang; Xinxin Chen; Tao Tian; Hongzhao You; Yulin Li; Muli Wu; Xiaoyu Du; He Cai; Yang Zheng; Jie Du
Journal:  Sci Rep       Date:  2020-04-14       Impact factor: 4.379

10.  Long-term outcomes of chronic coronary syndrome worldwide: insights from the international CLARIFY registry.

Authors:  Emmanuel Sorbets; Kim M Fox; Yedid Elbez; Nicolas Danchin; Paul Dorian; Roberto Ferrari; Ian Ford; Nicola Greenlaw; Paul R Kalra; Zofia Parma; Svetlana Shalnova; Jean-Claude Tardif; Michal Tendera; José Luis Zamorano; Emmanuelle Vidal-Petiot; Philippe Gabriel Steg
Journal:  Eur Heart J       Date:  2020-01-14       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.